Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03408587
Title CAVATAK and Ipilimumab in Uveal Melanoma Metastatic to the LIver (VLA-024 CLEVER) (CLEVER)
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Viralytics
Indications

uveal melanoma

Therapies

Coxsackievirus A21 + Ipilimumab

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.